Figure 4

Kaplan-Meier overall survival curves by subtype of breast cancer. (A) Hormone receptor-positive, HER2-negative breast cancer patients with high expression group of VEGFR-1 mRNA showed significantly poorer prognosis (P <0.01, log rank test). (B) Triple negative breast cancer patients with high expression group of VEGFR-1 mRNA showed significantly poorer prognosis (P <0.05, log rank test).